Hypoplastic Left Heart Syndrome
Hypoplastic left heart syndrome (HLHS) is a rare and complex form of congenital heart disease in which the left side of a child's heart is severely underdeveloped. Today, treatment normally involves a three-stage surgery to reroute blood flow in the heart.
Though effective, these surgeries do not eliminate the chance that an HLHS patient may need a heart transplant in the future.
In the Todd and Karen Wanek Family Program for HLHS, a diverse group of Mayo Clinic physicians and researchers led by Timothy J. Nelson, M.D., Ph.D., of Mayo Clinic in Rochester, Minn., are working to launch clinical trials that bring the latest advances in cell therapy to people with HLHS.
Within the program, teams are:
Visit the HLHS News and Views blog for the latest research developments, patient stories and other information from Mayo Clinic researchers, physicians and staff.
More information about the program is on the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome website.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.